Synthetic psychoactive drugs (SPDs) pose a significant public health challenge. This guide delves into the complexities surrounding these substances, offering insights into their mechanisms of action, health effects, and current research efforts aimed at prevention and treatment.
Background
Synthetic psychoactive drugs are designed to mimic the effects of known illicit drugs. Their constantly evolving chemical structures and marketing tactics present challenges for health officials and law enforcement. These substances can bypass legal definitions, making them difficult to control. The unpredictable nature of SPDs necessitates ongoing research to understand their effects, identify patterns of use, and develop effective countermeasures.
The surge in SPD use over the past decade is a major public health concern. Research efforts are crucial for informing researchers, clinicians, emergency personnel, and policymakers about epidemiologic trends, mechanisms of action, and clinical strategies to mitigate the consequences of SPD use.
Classification of Synthetic Psychoactive Drugs
SPDs can be categorized into several classes:
-
Synthetic Cannabinoids (SP Cannabinoids): These substances mimic the effects of THC, the active ingredient in marijuana. They are often found in herbal products and can be more potent and unpredictable than marijuana. Examples include JWH compounds.
-
Synthetic Cathinones (SP Cathinones): These substances mimic the effects of stimulants. They interact with various physiological targets, resulting in a range of effects from powerful stimulation to hallucinogenic experiences. Examples include methylone and MDPV (3,4-methylenedioxypyrovalerone).
-
Synthetic Opiates (SP Opiates): These substances mimic the effects of opiates. They tend to be more potent analgesics than morphine, with faster onset and shorter half-lives. They also carry a higher risk of addiction. Examples include acetyl fentanyl.
-
Synthetic Hallucinogens (SP Hallucinogens): These substances are structurally related to mescaline and exhibit hallucinogenic properties. They can also have severe toxic effects.
-
Other SPDs: This category includes emerging SPDs that are currently used overseas and have the potential for abuse in the US.
-
Designer Cocktails: These generally refer to the mixture and abuse of prescription pharmaceuticals. (Note: This is not a primary focus of the research outlined here).
Research Objectives and Categories
Research efforts focus on understanding the receptor targets, signaling pathways, neurodevelopmental, and neurocircuitry effects of SPDs. While detailed information about their pharmacology, toxicology, and metabolism is limited, some SPDs have shown potent activity at monoamine neurotransmitter and endocannabinoid systems. Furthermore, they demonstrate addictive properties, inducing intense cravings, tolerance, dependence, and withdrawal symptoms.
Research is categorized into the following areas:
-
Epidemiological and Prevention Research: Studies examining rates and patterns of SPD use, risk factors for initiation and continuation of use, social and environmental influences, and the development of prevention messages. This includes monitoring emergency department visits and leveraging social media for early detection.
-
Basic and Preclinical Research: Studies on the stability, pharmacokinetic and pharmacodynamic profiles of SPDs. This includes receptor binding properties, neurotransmitter release and uptake, addiction liability in animal models, and identification of biomarkers.
-
Human Studies and Clinical Research: Psychopharmacological studies measuring subjective drug effects, effects on cognition and reinforcement processes, and brain structure and function. Research also includes the study of effects on sleep, complex behaviors, and the influence of genetic variations.
-
Medical Consequences and Therapeutic Approaches: Clinical research to study short- and long-term health consequences associated with SPDs, particularly cathinones and synthetic cannabinoids. This includes neurological, psychiatric, cardiovascular, and other physiological effects, as well as studies examining interventions to ameliorate toxicological consequences.
Special Considerations
Research involving the administration of drugs with abuse potential to human subjects requires careful consideration. Guidelines from the National Advisory Council on Drug Abuse (NACDA) should be reviewed before submitting an application.
Funding and Eligibility
Funding is provided through grants. Eligible applicants include higher education institutions, non-profit organizations, for-profit organizations, and government entities. Foreign institutions are also eligible to apply.
Application and Submission
Applications must be submitted electronically following the instructions in the SF424 (R&R) Application Guide. Compliance with application instructions is mandatory.
Review Process
Applications are reviewed for scientific and technical merit by Scientific Review Groups convened by the Center for Scientific Review, NIH. Review criteria include significance, investigator(s), innovation, approach, and environment.
Conclusion
Understanding synthetic psychoactive drugs is crucial for addressing the growing public health crisis. Continued research into the epidemiology, mechanisms of action, and health consequences of these substances is essential for developing effective prevention and treatment strategies.
Disclaimer: This guide provides a general overview of synthetic psychoactive drugs and related research. It is not intended to provide medical advice. Consult with a healthcare professional for diagnosis and treatment of any medical condition.
